Skye Bioscence’s $40 Million Private Placement Equity Financing

Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction.Skye Bioscience, Inc. (OTCQB: SKYE) has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here